Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;96(1139):550-555.
doi: 10.1136/postgradmedj-2020-137785. Epub 2020 Apr 15.

Hydroxychloroquine and COVID-19

Neeraj Sinha  1 , Galit Balayla  2
Affiliations
Review

Hydroxychloroquine and COVID-19

Neeraj Sinha et al. Postgrad Med J. 2020 Sep.

Abstract

Hydroxychloroquine and chloroquine are medications that have been used for a long time. Their most common use is for the treatment and prophylaxis of malaria. However, these antimalarial drugs are known to also have anti-inflammatory and antiviral effects and are used for several chronic diseases such as systemic lupus erythematosus with low adverse effects. The antiviral action of hydroxychloroquine and chloroquine has been a point of interest to different researchers due to its mechanism of action. Several in vitro studies have proven their effectiveness on severe acute respiratory syndrome virus and currently both in vitro and in vivo studies have been conducted on 2019 novel coronavirus (covid-19). The purpose of this article is to review the history and mechanism of actions of these drugs and the potential use they can have on the current covid-19 pandemic.

Keywords: thoracic medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Mates M, Nesher G, Zevin S. [Quinines--past and present]. Harefuah 2007;146:560–2. - PubMed
    1. D'Cruz D. Lupus and the art of clinical medicine. Rheumatology 2015;54:i6–7.
    1. Tanenbaum L, Tuffanelli DL. Antimalarial agents. chloroquine, hydroxychloroquine, and quinacrine. Arch Dermatol 1980;116:587–91.10.1001/archderm.116.5.587 - DOI - PubMed
    1. Page F. Treatment of lupus erythematosus with mepacrine. Lancet 1951;2:755–8.10.1016/S0140-6736(51)91643-1 - DOI - PubMed
    1. Clark P, Casas E, Tugwell P, et al. Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial. Ann Intern Med 1993;119:1067–71.10.7326/0003-4819-119-11-199312010-00002 - DOI - PubMed